Zobrazeno 1 - 10 of 54 pro vyhledávání: '"Fw, Quelle"'
1
Erythropoietin induces association of the JAK2 protein tyrosine kinase with the erythropoietin receptor in vivo
Autor: O Miura, N Nakamura, FW Quelle, BA Witthuhn, JN Ihle, N Aoki
Publikováno v: Blood. 84:1501-1507
Protein tyrosine phosphorylation has been hypothesized to play a key role in the growth signaling induced by erythropoietin (Epo), although the Epo receptor (EpoR), a member of the cytokine receptor superfamily, lacks a tyrosine kinase domain. Recent
Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_________::3ba92f01f6563799cb1964317dede565
https://doi.org/10.1182/blood.v84.5.1501.1501
Zobrazit plný text záznamu
2
Interleukin 3, granulocyte-macrophage colony-stimulating factor, and transfected erythropoietin receptors mediate tyrosine phosphorylation of a common cytosolic protein (pp100) in FDC-ER cells
Autor: Fw, Quelle, Dawn Quelle, Dm, Wojchowski
Publikováno v: Europe PubMed Central
Receptors for the hematopoietic growth factors erythropoietin, interleukin 3 (IL-3), and granulocyte-macrophage colony-stimulating factor (GM-CSF) are members of a structurally related receptor superfamily. Interestingly, while none of these receptor
Externí odkaz: https://explore.openaire.eu/search/publication?articleId=pmid_dedup__::1025135fc561fd9716d9514088d827ad
https://pubmed.ncbi.nlm.nih.gov/1324920
Zobrazit plný text záznamu
3
Akademický článek
RhoBTB1 reverses established arterial stiffness in angiotensin II-induced hypertension by promoting actin depolymerization.
Autor: Fang S; Department of Physiology and Cardiovascular Center, Medical College of Wisconsin, Milwaukee, Wisconsin, USA.; Department of Neuroscience and Pharmacology, Carver College of Medicine, University of Iowa, Iowa City, Iowa, USA., Wu J; Department of Physiology and Cardiovascular Center, Medical College of Wisconsin, Milwaukee, Wisconsin, USA., Reho JJ; Department of Physiology and Cardiovascular Center, Medical College of Wisconsin, Milwaukee, Wisconsin, USA., Lu KT; Department of Physiology and Cardiovascular Center, Medical College of Wisconsin, Milwaukee, Wisconsin, USA., Brozoski DT; Department of Physiology and Cardiovascular Center, Medical College of Wisconsin, Milwaukee, Wisconsin, USA., Kumar G; Department of Physiology and Cardiovascular Center, Medical College of Wisconsin, Milwaukee, Wisconsin, USA., Werthman AM; Department of Physiology and Cardiovascular Center, Medical College of Wisconsin, Milwaukee, Wisconsin, USA., Silva SD Jr; Department of Physiology and Cardiovascular Center, Medical College of Wisconsin, Milwaukee, Wisconsin, USA., Muskus Veitia PC; Department of Physiology and Cardiovascular Center, Medical College of Wisconsin, Milwaukee, Wisconsin, USA., Wackman KK; Department of Physiology and Cardiovascular Center, Medical College of Wisconsin, Milwaukee, Wisconsin, USA., Mathison AJ; Genomic Sciences and Precision Medicine Center.; Division of Research, Department of Surgery; and., Teng BQ; Division of Biostatistics, Medical College of Wisconsin, Milwaukee, Wisconsin, USA., Lin CW; Division of Biostatistics, Medical College of Wisconsin, Milwaukee, Wisconsin, USA., Quelle FW; Department of Neuroscience and Pharmacology, Carver College of Medicine, University of Iowa, Iowa City, Iowa, USA., Sigmund CD; Department of Physiology and Cardiovascular Center, Medical College of Wisconsin, Milwaukee, Wisconsin, USA.
Publikováno v: JCI insight [JCI Insight] 2022 May 09; Vol. 7 (9). Date of Electronic Publication: 2022 May 09.
Zobrazit plný text záznamu
4
Akademický článek
Conditional deletion of smooth muscle Cullin-3 causes severe progressive hypertension.
Autor: Agbor LN; Department of Pharmacology, Roy J. and Lucille A. Carver College of Medicine, University of Iowa, Iowa City, Iowa, USA., Nair AR; Department of Pharmacology, Roy J. and Lucille A. Carver College of Medicine, University of Iowa, Iowa City, Iowa, USA., Wu J; Department of Pharmacology, Roy J. and Lucille A. Carver College of Medicine, University of Iowa, Iowa City, Iowa, USA.; Department of Physiology, Medical College of Wisconsin, Milwaukee, Wisconsin, USA., Lu KT; Department of Pharmacology, Roy J. and Lucille A. Carver College of Medicine, University of Iowa, Iowa City, Iowa, USA.; Department of Physiology, Medical College of Wisconsin, Milwaukee, Wisconsin, USA., Davis DR; Department of Pharmacology, Roy J. and Lucille A. Carver College of Medicine, University of Iowa, Iowa City, Iowa, USA., Keen HL; Department of Pharmacology, Roy J. and Lucille A. Carver College of Medicine, University of Iowa, Iowa City, Iowa, USA., Quelle FW; Department of Pharmacology, Roy J. and Lucille A. Carver College of Medicine, University of Iowa, Iowa City, Iowa, USA., McCormick JA; Division of Nephrology & Hypertension, Department of Medicine, Oregon Health & Science University, Portland, Oregon, USA., Singer JD; Department of Biology, Portland State University, Portland, Oregon, USA., Sigmund CD; Department of Pharmacology, Roy J. and Lucille A. Carver College of Medicine, University of Iowa, Iowa City, Iowa, USA.; Department of Physiology, Medical College of Wisconsin, Milwaukee, Wisconsin, USA.
Publikováno v: JCI insight [JCI Insight] 2019 Jun 11; Vol. 5. Date of Electronic Publication: 2019 Jun 11.
Zobrazit plný text záznamu
5
Akademický článek
RhoBTB1 protects against hypertension and arterial stiffness by restraining phosphodiesterase 5 activity.
Autor: Mukohda M; Department of Pharmacology, UIHC Center for Hypertension Research, Roy J. and Lucille A. Carver College of Medicine, University of Iowa, Iowa City, Iowa, USA., Fang S; Department of Pharmacology, UIHC Center for Hypertension Research, Roy J. and Lucille A. Carver College of Medicine, University of Iowa, Iowa City, Iowa, USA.; Department of Physiology, Cardiovascular Center, Medical College of Wisconsin, Milwaukee, Wisconsin, USA., Wu J; Department of Pharmacology, UIHC Center for Hypertension Research, Roy J. and Lucille A. Carver College of Medicine, University of Iowa, Iowa City, Iowa, USA.; Department of Physiology, Cardiovascular Center, Medical College of Wisconsin, Milwaukee, Wisconsin, USA., Agbor LN; Department of Pharmacology, UIHC Center for Hypertension Research, Roy J. and Lucille A. Carver College of Medicine, University of Iowa, Iowa City, Iowa, USA., Nair AR; Department of Pharmacology, UIHC Center for Hypertension Research, Roy J. and Lucille A. Carver College of Medicine, University of Iowa, Iowa City, Iowa, USA., Ibeawuchi SC; Department of Pharmacology, UIHC Center for Hypertension Research, Roy J. and Lucille A. Carver College of Medicine, University of Iowa, Iowa City, Iowa, USA., Hu C; Department of Pharmacology, UIHC Center for Hypertension Research, Roy J. and Lucille A. Carver College of Medicine, University of Iowa, Iowa City, Iowa, USA., Liu X; Department of Pharmacology, UIHC Center for Hypertension Research, Roy J. and Lucille A. Carver College of Medicine, University of Iowa, Iowa City, Iowa, USA., Lu KT; Department of Pharmacology, UIHC Center for Hypertension Research, Roy J. and Lucille A. Carver College of Medicine, University of Iowa, Iowa City, Iowa, USA.; Department of Physiology, Cardiovascular Center, Medical College of Wisconsin, Milwaukee, Wisconsin, USA., Guo DF; Department of Pharmacology, UIHC Center for Hypertension Research, Roy J. and Lucille A. Carver College of Medicine, University of Iowa, Iowa City, Iowa, USA., Davis DR; Department of Pharmacology, UIHC Center for Hypertension Research, Roy J. and Lucille A. Carver College of Medicine, University of Iowa, Iowa City, Iowa, USA., Keen HL; Department of Pharmacology, UIHC Center for Hypertension Research, Roy J. and Lucille A. Carver College of Medicine, University of Iowa, Iowa City, Iowa, USA., Quelle FW; Department of Pharmacology, UIHC Center for Hypertension Research, Roy J. and Lucille A. Carver College of Medicine, University of Iowa, Iowa City, Iowa, USA., Sigmund CD; Department of Pharmacology, UIHC Center for Hypertension Research, Roy J. and Lucille A. Carver College of Medicine, University of Iowa, Iowa City, Iowa, USA.; Department of Physiology, Cardiovascular Center, Medical College of Wisconsin, Milwaukee, Wisconsin, USA.
Publikováno v: The Journal of clinical investigation [J Clin Invest] 2019 Mar 21; Vol. 129 (6), pp. 2318-2332. Date of Electronic Publication: 2019 Mar 21.
Zobrazit plný text záznamu
6
Akademický článek
RABL6A inhibits tumor-suppressive PP2A/AKT signaling to drive pancreatic neuroendocrine tumor growth.
Autor: Umesalma S; Department of Pharmacology., Kaemmer CA; Department of Pharmacology., Kohlmeyer JL; Molecular Medicine Graduate Program., Letney B; Department of Pharmacology., Schab AM; Department of Pharmacology., Reilly JA; Department of Pharmacology., Sheehy RM; Department of Pharmacology.; Free Radical & Radiation Biology Training Program., Hagen J; Department of Pharmacology., Tiwari N; Department of Pharmacology., Zhan F; Department of Internal Medicine, and., Leidinger MR; Department of Pathology, in the College of Medicine, Holden Comprehensive Cancer Center, University of Iowa, Iowa City, Iowa, USA., O'Dorisio TM; Department of Internal Medicine, and., Dillon J; Department of Internal Medicine, and., Merrill RA; Department of Pharmacology., Meyerholz DK; Department of Pathology, in the College of Medicine, Holden Comprehensive Cancer Center, University of Iowa, Iowa City, Iowa, USA., Perl AL; Department of Pharmacology, Case Western Reserve University, Cleveland, Ohio, USA., Brown BJ; Departments of Biomedical Engineering., Braun TA; Departments of Biomedical Engineering., Scott AT; Surgery., Ginader T; Biostatistics, and., Taghiyev AF; Pediatrics, Colleges of Medicine, Engineering, or Public Health, University of Iowa, Iowa City, Iowa, USA., Zamba GK; Biostatistics, and., Howe JR; Surgery., Strack S; Department of Pharmacology., Bellizzi AM; Department of Pathology, in the College of Medicine, Holden Comprehensive Cancer Center, University of Iowa, Iowa City, Iowa, USA., Narla G; Department of Medicine, University of Michigan, Ann Arbor, Michigan, USA., Darbro BW; Pediatrics, Colleges of Medicine, Engineering, or Public Health, University of Iowa, Iowa City, Iowa, USA., Quelle FW; Department of Pharmacology.; Department of Internal Medicine, and., Quelle DE; Department of Pharmacology.; Molecular Medicine Graduate Program.; Free Radical & Radiation Biology Training Program.; Department of Pathology, in the College of Medicine, Holden Comprehensive Cancer Center, University of Iowa, Iowa City, Iowa, USA.
Publikováno v: The Journal of clinical investigation [J Clin Invest] 2019 Mar 04; Vol. 129 (4), pp. 1641-1653. Date of Electronic Publication: 2019 Mar 04 (Print Publication: 2019).
Zobrazit plný text záznamu
7
Akademický článek
PPARγ and retinol binding protein 7 form a regulatory hub promoting antioxidant properties of the endothelium.
Autor: Woll AW; Department of Pharmacology, Roy J. and Lucille A. Carver College of Medicine, University of Iowa, Iowa City, Iowa.; Interdisciplinary Program in Molecular Medicine, Roy J. and Lucille A. Carver College of Medicine, University of Iowa, Iowa City, Iowa., Quelle FW; Department of Pharmacology, Roy J. and Lucille A. Carver College of Medicine, University of Iowa, Iowa City, Iowa., Sigmund CD; Department of Pharmacology, Roy J. and Lucille A. Carver College of Medicine, University of Iowa, Iowa City, Iowa; curt-sigmund@uiowa.edu.; UIHC Center for Hypertension Research, Roy J. and Lucille A. Carver College of Medicine, University of Iowa, Iowa City, Iowa; and.
Publikováno v: Physiological genomics [Physiol Genomics] 2017 Nov 01; Vol. 49 (11), pp. 653-658. Date of Electronic Publication: 2017 Sep 15.
Zobrazit plný text záznamu
8
Akademický článek
Hypertension-Causing Mutation in Peroxisome Proliferator-Activated Receptor γ Impairs Nuclear Export of Nuclear Factor-κB p65 in Vascular Smooth Muscle.
Autor: Mukohda M; From the Department of Pharmacology and UIHC Center for Hypertension Research, Roy J. and Lucille A. Carver College of Medicine, University of Iowa., Lu KT; From the Department of Pharmacology and UIHC Center for Hypertension Research, Roy J. and Lucille A. Carver College of Medicine, University of Iowa., Guo DF; From the Department of Pharmacology and UIHC Center for Hypertension Research, Roy J. and Lucille A. Carver College of Medicine, University of Iowa., Wu J; From the Department of Pharmacology and UIHC Center for Hypertension Research, Roy J. and Lucille A. Carver College of Medicine, University of Iowa., Keen HL; From the Department of Pharmacology and UIHC Center for Hypertension Research, Roy J. and Lucille A. Carver College of Medicine, University of Iowa., Liu X; From the Department of Pharmacology and UIHC Center for Hypertension Research, Roy J. and Lucille A. Carver College of Medicine, University of Iowa., Ketsawatsomkron P; From the Department of Pharmacology and UIHC Center for Hypertension Research, Roy J. and Lucille A. Carver College of Medicine, University of Iowa., Stump M; From the Department of Pharmacology and UIHC Center for Hypertension Research, Roy J. and Lucille A. Carver College of Medicine, University of Iowa., Rahmouni K; From the Department of Pharmacology and UIHC Center for Hypertension Research, Roy J. and Lucille A. Carver College of Medicine, University of Iowa., Quelle FW; From the Department of Pharmacology and UIHC Center for Hypertension Research, Roy J. and Lucille A. Carver College of Medicine, University of Iowa., Sigmund CD; From the Department of Pharmacology and UIHC Center for Hypertension Research, Roy J. and Lucille A. Carver College of Medicine, University of Iowa. curt-sigmund@uiowa.edu.
Publikováno v: Hypertension (Dallas, Tex. : 1979) [Hypertension] 2017 Jul; Vol. 70 (1), pp. 174-182. Date of Electronic Publication: 2017 May 15.
Zobrazit plný text záznamu
9
Akademický článek
Retinol-binding protein 7 is an endothelium-specific PPAR γ cofactor mediating an antioxidant response through adiponectin.
Autor: Hu C; Department of Pharmacology., Keen HL; Department of Pharmacology., Lu KT; Department of Pharmacology., Liu X; Department of Pharmacology., Wu J; Department of Pharmacology., Davis DR; Department of Pharmacology., Ibeawuchi SC; Department of Pharmacology., Vogel S; Duke-NUS Medical School, Singapore, Singapore., Quelle FW; Department of Pharmacology., Sigmund CD; Department of Pharmacology.; UIHC Center for Hypertension Research, Roy J. and Lucille A. Carver College of Medicine, University of Iowa, Iowa City, Iowa, USA.
Publikováno v: JCI insight [JCI Insight] 2017 Mar 23; Vol. 2 (6), pp. e91738. Date of Electronic Publication: 2017 Mar 23.
Zobrazit plný text záznamu
10
Akademický článek
Cullin-3 mutation causes arterial stiffness and hypertension through a vascular smooth muscle mechanism.
Autor: Agbor LN; Department of Pharmacology and., Ibeawuchi SC; Department of Pharmacology and., Hu C; Department of Pharmacology and., Wu J; Department of Pharmacology and., Davis DR; Department of Pharmacology and., Keen HL; Department of Pharmacology and., Quelle FW; Department of Pharmacology and., Sigmund CD; Department of Pharmacology and.; UIHC for Hypertension Research, Roy J. and Lucille A. Carver College of Medicine, University of Iowa, Iowa City, Iowa, USA.
Publikováno v: JCI insight [JCI Insight] 2016 Nov 17; Vol. 1 (19), pp. e91015. Date of Electronic Publication: 2016 Nov 17.
Zobrazit plný text záznamu

Vyhledávací nástroje:

Upřesnit hledání

Omezení vyhledávání
Plný text Recenzováno Digitální knihovna AV ČR
Zdroje